XML 54 R38.htm IDEA: XBRL DOCUMENT v3.5.0.1
Business, Acquisition of Assets and Basis of Presentation (Details Textual)
 1 Months Ended 9 Months Ended 12 Months Ended
Jun. 08, 2015
Oct. 31, 2015
USD ($)
Sep. 30, 2015
USD ($)
May 31, 2015
USD ($)
Mar. 31, 2016
USD ($)
Mar. 31, 2015
USD ($)
Jun. 30, 2015
USD ($)
Jun. 30, 2014
USD ($)
Oct. 05, 2015
USD ($)
May 20, 2015
USD ($)
Business Acquisition [Line Items]                    
Other Labor-related Expenses             $ 264,000 $ 253,000    
Sale of Stock, Percentage of Ownership after Transaction             81.50%      
Stockholders' Equity, Reverse Stock Split         On June 8, 2015, in connection with the reincorporation as a Delaware corporation, the Company effected a reverse stock split in which each common stock holder received one share of common stock for every 12.174 shares then outstanding (the “Reverse Stock Split”).   On June 8, 2015, in connection with the reincorporation as a Delaware corporation, we effected a reverse stock split in which each common stock holder received one share of common stock for each every 12.174 shares then outstanding (the “Reverse Stock Split”).      
Stockholders' Equity Note, Stock Split, Conversion Ratio 12.174                  
Payments to Acquire Businesses, Gross         $ 540,000 $ 0 $ 1,000,000 0    
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset             664,000 0    
Amortization of Intangible Assets             $ 71,000 $ 70,000    
Business Combination, Contingent Consideration, Liability, Total         1,155,000          
Developed Technology Rights [Member]                    
Business Acquisition [Line Items]                    
Amortization of Intangible Assets         520,000          
Trade Names [Member]                    
Business Acquisition [Line Items]                    
Amortization of Intangible Assets         140,000          
Customer Contracts [Member]                    
Business Acquisition [Line Items]                    
Amortization of Intangible Assets         $ 810,000          
Prostascint Business [Member]                    
Business Acquisition [Line Items]                    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total       $ 2,400,000         $ 1,799,000 $ 2,391,000
Payments to Acquire Businesses, Gross       1,000,000            
Business Combination, Consideration Transferred, Liabilities Incurred       227,000            
Restructuring payment, contingent consideration         Aytu also will pay 8% as contingent consideration on its net sales made after October 31, 2017, payable up to a maximum aggregate payment of an additional $2.5 million.   Aytu also will pay 8% as contingent consideration on its net sales made after October 31, 2017, payable up to a maximum aggregate payment of an additional $2.5 million.      
Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High       $ 2,500,000            
Contingent consideration percentage       8.00%            
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset       $ 664,000 $ 699,000          
Business Combination Consideration Transferred Product Inventory       $ 500,000            
Prostascint Business [Member] | Scenario, Forecast [Member]                    
Business Acquisition [Line Items]                    
Business Combination, Consideration Transferred, Liabilities Incurred     $ 227,000              
Jazz Pharmaceuticals Inc [Member] | Prosta Scint [Member] | Maximum [Member]                    
Business Acquisition [Line Items]                    
Finite-Lived Intangible Assets, Remaining Amortization Period         10 years          
Jazz Pharmaceuticals Inc [Member] | Prosta Scint [Member] | Developed Technology Rights [Member]                    
Business Acquisition [Line Items]                    
Finite-Lived Intangible Assets, Gross         $ 790,000          
Jazz Pharmaceuticals Inc [Member] | Prosta Scint [Member] | Trade Names [Member]                    
Business Acquisition [Line Items]                    
Finite-Lived Intangible Assets, Gross         80,000          
Jazz Pharmaceuticals Inc [Member] | Prosta Scint [Member] | Customer Contracts [Member]                    
Business Acquisition [Line Items]                    
Finite-Lived Intangible Assets, Gross         720,000          
Primsol Business [Member]                    
Business Acquisition [Line Items]                    
Payments to Acquire Businesses, Gross   $ 500,000                
Business Combination, Consideration Transferred, Liabilities Incurred   142,000                
Business Combination Consideration Transferred Inventory   102,000     102,000          
Business Combination Consideration Transferred Product Inventory   40,000                
Business Combination Consideration Transferred Work In Process Inventory         $ 80,000          
Primsol Business [Member] | Maximum [Member]                    
Business Acquisition [Line Items]                    
Finite-Lived Intangible Assets, Remaining Amortization Period         6 years          
Primsol Business [Member] | Paid on April 1, 2016 [Member]                    
Business Acquisition [Line Items]                    
Business Combination, Consideration Transferred, Liabilities Incurred   500,000                
Primsol Business [Member] | No Later Than June 30, 2016 [Member]                    
Business Acquisition [Line Items]                    
Business Combination, Consideration Transferred, Liabilities Incurred   500,000                
Primsol Business [Member] | No Later Than September 30, 2016 [Member]                    
Business Acquisition [Line Items]                    
Business Combination, Consideration Transferred, Liabilities Incurred   $ 250,000